EN | UA
EN | UA

Help Support

Back

Rifabutin triple therapy emerges as promising option for H. pylori rescue treatment

H. pylori rescue treatment H. pylori rescue treatment
H. pylori rescue treatment H. pylori rescue treatment

What's new?

Rifabutin-containing triple therapy can be considered as an alternative to conventional Bismuth quadruple therapy for rescue treatment of H. pylori infection.

In a multicenter, randomized controlled trial, Rifabutin triple therapy presented as an effective alternative approach to the traditional Bismuth quadruple therapy as it offered the advantage of reduced side effects and improved patient adherence in people with Helicobacter pylori (H. pylori) infection. Researchers aimed to assess the effectiveness and safety of Rifabutin-containing triple therapy in contrast to Bismuth quadruple therapy for H. pylori elimination.

Participants (n = 364) who had experienced two or more unsuccessful treatments were included in the study. They were randomly divided into two groups:

  • One group received a 14-day course of Rifabutin triple therapy, consisting of Esomeprazole (20 mg), Amoxicillin (1.0 g), and Rifabutin (150 mg) taken two times per day.
  • The other group underwent Bismuth quadruple therapy, which involved taking Bismuth (220 mg) and Esomeprazole (20 mg) twice a day, along with Tetracycline (500 mg) and Metronidazole (400 mg) 4 times per day.

The study assessed the susceptibility of the bacteria to these antimicrobial treatments using agar dilution and E-test methods. The rate of H. pylori elimination for the Bismuth quadruple therapy group and Rifabutin triple therapy group, as determined by modified intention-to-treat (mITT), per-protocol (PP), and intention-to-treat (ITT) analyses, are depicted in Table 1:

Therefore, Rifabutin triple therapy appears to be a viable substitute to traditional Bismuth quadruple therapy for rescue treatment of H. pylori, with lesser side effects and higher adherence.

Source:

The Journal of Infectious Diseases

Article:

Rifabutin-Containing Triple Therapy Versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial

Authors:

Jinnan Chen et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: